Clinical Trial Update: Sulindac in Preventing Melanoma in Healthy Participants Who Are at Increased Risk of Melanoma [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating whether sulindac can prevent melanoma in healthy individuals at increased risk; trial completed with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma
• Precancerous Condition

Drugs mentioned

• Sulindac (sulindac)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Precancerous Condition | Phase 2 | Status: COMPLETED | Results posted: 2012-03-16